Revance price target raised to $16 from $15 at Guggenheim

Guggenheim raised the firm’s price target on Revance to $16 from $15 and keeps a Buy rating on the shares as the firm is updating its model post Q4 results. Given that seasonality is expected to impact Q1 sales, Q2 should offer a meaningful opportunity for Revance to deliver share gains and business acceleration, the analyst tells investors in a post-earnings note.